Piper Jaffray Starts GlaxoSmithKline (GSK) at Overweight

September 23, 2016 7:14 AM EDT
Get Alerts GSK Hot Sheet
Price: $37.70 +0.72%

Rating Summary:
    6 Buy, 10 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 11 | Down: 31 | New: 42
Trade GSK Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Piper Jaffray initiated coverage on GlaxoSmithKline (NYSE: GSK) with an Overweight rating.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $43.58 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Piper Jaffray

Add Your Comment